These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 7187045
1. Cation fluxes in erythrocytes of patients with endogenous depression in the course of treatment with antidepressant drugs. Rybakowski J, Potok E, Strzyzewski W, Markowski S. Pol J Pharmacol Pharm; 1982; 34(5-6):295-301. PubMed ID: 7187045 [Abstract] [Full Text] [Related]
2. Ouabain-sensitive sodium and potassium fluxes in red blood cells of patients with endogenous depressive syndromes. Potok E, Rybakowski J. Pol J Pharmacol Pharm; 1981; 33(1):53-8. PubMed ID: 7255280 [Abstract] [Full Text] [Related]
3. The effects of lithium treatment on cation transport processes in erythrocytes of patients with affective illnesses. Rybakowski J, Potok E, Strzyzewski W, Chłopocka-Woźniak M. Pol J Pharmacol Pharm; 1983; 35(3):209-15. PubMed ID: 6622301 [Abstract] [Full Text] [Related]
7. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment. Revicki DA, Simon GE, Chan K, Katon W, Heiligenstein J. J Fam Pract; 1998 Dec; 47(6):446-52. PubMed ID: 9866670 [Abstract] [Full Text] [Related]
11. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment. Hellweg R, Ziegenhorn A, Heuser I, Deuschle M. Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687 [Abstract] [Full Text] [Related]
13. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression. Cohn CK, Robinson DS, Roberts DL, Schwiderski UE, O'Brien K, Ieni JR. J Clin Psychiatry; 1996 Mar; 57 Suppl 2():15-8. PubMed ID: 8626358 [Abstract] [Full Text] [Related]
14. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients. Mendels J, Reimherr F, Marcus RN, Roberts DL, Francis RJ, Anton SF. J Clin Psychiatry; 1995 Mar; 56 Suppl 6():30-6. PubMed ID: 7649971 [Abstract] [Full Text] [Related]
15. Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients. Feighner JP, Sverdlov L, Hlavka J, Nicolau G, Cartwright K, Freed JS. Int Clin Psychopharmacol; 2008 Jan; 23(1):29-35. PubMed ID: 18090505 [Abstract] [Full Text] [Related]
19. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city]. Mouchabac S, Ferreri M, Cabanac F, Bitton M. Encephale; 2003 Jan; 29(5):438-44. PubMed ID: 14615693 [Abstract] [Full Text] [Related]